Changes in Optic Nerve Head and Retinal Morphology During Spaceflight and Acute Fluid Shift Reversal.


Journal

JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539

Informations de publication

Date de publication:
01 08 2022
Historique:
pubmed: 17 6 2022
medline: 23 8 2022
entrez: 16 6 2022
Statut: ppublish

Résumé

Countermeasures that reverse the headward fluid shift experienced in weightlessness have the potential to mitigate spaceflight-associated neuro-ocular syndrome. This study investigated whether use of the countermeasure lower-body negative pressure during spaceflight was associated with changes in ocular structure. To determine whether changes to the optic nerve head and retina during spaceflight can be mitigated by brief in-flight application of 25-mm Hg lower-body negative pressure. In the National Aeronautics and Space Administration's "Fluid Shifts Study," a prospective cohort study, optical coherence tomography scans of the optic nerve head and macula were obtained from US and international crew members before flight, in-flight, and up to 180 days after return to Earth. In-flight scans were obtained both under normal weightless conditions and 10 to 20 minutes into lower-body negative pressure exposure. Preflight and postflight data were collected in the seated, supine, and head-down tilt postures. Crew members completed 6- to 12-month missions that took place on the International Space Station. Data were analyzed from 2016 to 2021. Spaceflight and lower-body negative pressure. Changes in minimum rim width, optic cup volume, Bruch membrane opening height, peripapillary total retinal thickness, and macular thickness. Mean (SD) flight duration for the 14 crew members (mean [SD] age, 45 [6] years; 11 male crew members [79%]) was 214 (72) days. Ocular changes on flight day 150, as compared with preflight seated, included an increase in minimum rim width (33.8 μm; 95% CI, 27.9-39.7 μm; P < .001), decrease in cup volume (0.038 mm3; 95% CI, 0.030-0.046 mm3; P < .001), posterior displacement of Bruch membrane opening (-9.0 μm; 95% CI, -15.7 to -2.2 μm; P = .009), and decrease in macular thickness (fovea to 500 μm, 5.1 μm; 95% CI, 3.5-6.8 μm; P < .001). Brief exposure to lower-body negative pressure did not affect these parameters. Results of this cohort study suggest that peripapillary tissue thickening, decreased cup volume, and mild central macular thinning were associated with long-duration spaceflight. Acute exposure to 25-mm Hg lower-body negative pressure did not alter optic nerve head or retinal morphology, suggesting that longer durations of a fluid shift reversal may be needed to mitigate spaceflight-induced changes and/or other factors are involved.

Identifiants

pubmed: 35708665
pii: 2793385
doi: 10.1001/jamaophthalmol.2022.1946
pmc: PMC9204621
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

763-770

Commentaires et corrections

Type : ErratumIn
Type : CommentIn
Type : CommentIn

Auteurs

Laura P Pardon (LP)

KBR, Houston, Texas.

Brandon R Macias (BR)

National Aeronautics and Space Administration Johnson Space Center, Houston, Texas.

Connor R Ferguson (CR)

Aegis Aerospace, Houston, Texas.

Scott H Greenwald (SH)

KBR, Houston, Texas.

Robert Ploutz-Snyder (R)

School of Nursing, University of Michigan, Ann Arbor.

Irina V Alferova (IV)

Russian Federation State Research Center Institute of Biomedical Problems, Russian Academy of Sciences, Moscow, Russia.

Doug Ebert (D)

KBR, Houston, Texas.

Scott A Dulchavsky (SA)

Henry Ford Hospital, Detroit, Michigan.

Alan R Hargens (AR)

Department of Orthopedic Surgery, UC San Diego Medical Center, University of California, San Diego.

Michael B Stenger (MB)

National Aeronautics and Space Administration Johnson Space Center, Houston, Texas.

Steven S Laurie (SS)

KBR, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH